Abstract
Objective: The objective of this study was to assess the myocardial infarction (MI) risk chances among individuals in the productive age group using easy cardiovascular disease (EZ-CVD) risk assessment tool.
Methods: This is a prospective observational and interventional study conducted for 6 months after obtaining the Institutional Human Ethics Committee approval. EZ-CVD risk assessment tool was used in this study which includes six self-reporting questionaries’ such as age, gender, history of diabetes, history of smoking, history of hypertension, and family history of heart attack at the age of 60 or younger. A score of 6 or greater is considered as patients are at high risk of having MI.
Results: Sixty subjects were enrolled in to this study using the inclusion criteria. Among them, 36 were male and 24 individuals were female. Out of sixty recruited, 23 found having high risk for MI attack and 37 were at low risk of having chances of further MI.
Conclusion: The study conclude that EZ-CVD risk assessment tool was found useful to predict the occurrence of future MI.
Publisher
Innovare Academic Sciences Pvt Ltd
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference15 articles.
1. Moraga P, GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: A systematic analysis for the global burden of disease study 2016. Lancet 2017;390:1151-210.
2. Roth GA, Abate D, Abate KH. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the global burden of disease study 2017. Lancet 2018;392:1736-88. doi: 10.1016/S0140- 6736(18)32203-7
3. Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 2017;70:1-25. doi: 10.1016/j. jacc.2017.04.052, PMID 28527533
4. Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol 2019;74:2529-32. doi: 10.1016/j.jacc.2019.10.009, PMID 31727292
5. Kiani F, Hesabi N, Arbabisarjou A. Assessment of risk factors in patients with myocardial infraction. Glob J Health Sci 2015;8:255-9. doi: 10.5539/gjhs.v8n1p255